These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31404445)

  • 1. Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas.
    Al-Kawaaz M; Sanchez T; Kluk MJ
    J Hematop; 2019 Jun; 12(2):57-65. PubMed ID: 31404445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
    Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large single-institution retrospective analysis of aggressive B-cell lymphomas according to the 2016/2017 WHO classification.
    Jesionek-Kupnicka D; Braun M; Robak T; Kuncman W; Kordek R
    Adv Clin Exp Med; 2019 Oct; 28(10):1359-1365. PubMed ID: 31518494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Bischin AM; Dorer R; Aboulafia DM
    Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD38, CD39, and BCL2 differentiate disseminated forms of high-grade B-cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Marianini P; Lacheretz-Szablewski V; Almeras M; Moreaux J; Bret C
    Cytometry B Clin Cytom; 2024 Nov; 106(6):448-464. PubMed ID: 39295433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Pathological Features of Double-Hit and Triple-Hit High-Grade B-Cell Lymphomas: A Retrospective Study from Three Portuguese Tertiary Centers.
    Almeida R; Abrantes C; Gigliano D; Oliveira RC; Teixeira P; Viegas M; Rodrigues Â; Julião MJ
    Int J Hematol Oncol Stem Cell Res; 2022 Apr; 16(2):94-102. PubMed ID: 36304730
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
    Graef CM; Gödel P; Falderbaum P; Balke-Want H; Simon F; Sieg N; Naendrup JH; Neumann MA; Gillessen S; Bröckelmann PJ; Eichenauer DA; Borchmann P; von Tresckow B; Heger JM
    Eur J Haematol; 2022 May; 108(5):403-412. PubMed ID: 35090068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade B-cell lymphoma with 11q aberration in the HIV setting: a clinicopathological study of 10 cases and literature review.
    Chang J; Liang Y; Gao Y; Wu M; Lv F; Liu H; Sun L; Yue Z; Meng L; Zhang Y; Jin M
    Infect Agent Cancer; 2024 Sep; 19(1):42. PubMed ID: 39261841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Grade B-Cell Lymphoma (HGBL) with
    Tsai CC; Su YC; Bamodu OA; Chen BJ; Tsai WC; Cheng WH; Lee CH; Hsieh SM; Liu ML; Fang CL; Lin HT; Chen CL; Yeh CT; Lee WH; Ho CL; Lai SW; Tzeng HE; Hsieh YY; Chang CL; Zheng YM; Liu HW; Yen Y; Whang-Peng J; Chao TY
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
    J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.
    Hüttl KS; Staiger AM; Richter J; Ott MM; Kalmbach S; Klapper W; Biesdorf AS; Trümper L; Rosenwald A; Ziepert M; Horn H; Ott G
    Virchows Arch; 2021 Sep; 479(3):575-583. PubMed ID: 33655392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.
    de Jonge AV; Duetz C; Bruins WSC; Korst CLBM; Rentenaar R; Cosovic M; Eken M; Twickler I; Nijland M; van der Poel MWM; de Heer K; Klerk CPW; Strobbe L; Oosterveld M; Boersma R; Koene HR; Roemer MGM; van Werkhoven E; Chamuleau MED; Mutis T
    Blood Adv; 2024 Mar; 8(5):1094-1104. PubMed ID: 38191686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.
    Paik JH; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    BMC Cancer; 2014 Dec; 14():911. PubMed ID: 25472725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas.
    Tanaka Y; Momose S; Tabayashi T; Sawada K; Yamashita T; Higashi M; Sagawa M; Tokuhira M; Rosenwald A; Kizaki M; Tamaru JI
    Cancer Sci; 2020 Feb; 111(2):749-759. PubMed ID: 31849147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade B-Cell lymphoma with
    Rogers TS; Gardner JA; Devitt KA
    Autops Case Rep; 2019; 9(3):e2019090. PubMed ID: 31440479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling.
    Flori M; Schmid CA; Sumrall ET; Tzankov A; Law CW; Robinson MD; Müller A
    Blood; 2016 Mar; 127(11):1438-48. PubMed ID: 26729899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in pathological understanding of high-grade B cell lymphomas.
    Li S; Lin P; Medeiros LJ
    Expert Rev Hematol; 2018 Aug; 11(8):637-648. PubMed ID: 29989509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker.
    Hurwitz SN; Lockhart B; Önder Ö; Wu R; Sethi S; Aypar U; Siebert R; Dogan A; Pillai V; Elenitoba-Johnson KSJ; Lim MS
    Mod Pathol; 2023 Jul; 36(7):100170. PubMed ID: 36997001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1-phosphate receptors and integrins.
    Middle S; Coupland SE; Taktak A; Kidgell V; Slupsky JR; Pettitt AR; Till KJ
    Exp Hematol Oncol; 2015; 4():10. PubMed ID: 25938000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with
    Uchida A; Isobe Y; Uemura Y; Nishio Y; Sakai H; Kato M; Otsubo K; Hoshikawa M; Takagi M; Miura I
    BMC Clin Pathol; 2017; 17():21. PubMed ID: 29151814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.